Proceedings of the National Academy of Sciences, 1998 D, Westaway, G, Telling, S, Priola
openaire +3 more sources
Six convincing reasons for cooperative TSE literature work
, 2003 in: Proceedings Internationale Konferenz "Prion diseases - from basic research to intervention ...
Heynkes, R., Schütt-Abraham, I.
core
Therapeutic strategies in prion disease: current evidence, translational challenges, and emerging directions. [PDF]
Front NeurosciZhu Y, Bradford BM, Mabbott NA.
europepmc +1 more source
Prion disease mimicking rapidly progressive Alzheimer disease: case series and systematic review. [PDF]
J NeurolElgenidi A +6 more
europepmc +1 more source
AI-designed prion-capping proteins provide evidence that prion fibril ends are replication-competent surfaces that contribute to prion seeding activity and infectivity. [PDF]
mBioSlota JA +10 more
europepmc +1 more source
Cellular PrP<sup>CWD</sup> deposition identified at the maternal-foetal interface of chronic wasting disease-infected cervids. [PDF]
J Gen VirolCole J +5 more
europepmc +1 more source
The protein disulfide isomerase P4HB/PDIA1 modulates cellular and misfolded forms of the prion protein. [PDF]
PLoS PathogAmano G +4 more
europepmc +1 more source
Production and Enzymatic Degradation of Sup35NM, a Prion-Like Protein from Yeast
, 2005 Prion diseases, or transmissible spongiform encephalopathies (TSEs), including human Creutzfeld-Jakob disease (CJD) and bovine spongiform encephalopathy (BSE), are fatal neurodegenerative diseases of humans and animals that are caused by aggregates of ...
Rojanatavorn, Kawan
core